Prescription drug · ANDA
Alprazolam NDC 0228-2029
Alprazolam .5 mg/1 · Tablet · Oral · Actavis Pharma, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0228-2029-10 | 00228202910 | 100 TABLET in 1 BOTTLE (0228-2029-10)Marketed from Oct 1, 1993 | |
| 0228-2029-50 | 00228202950 | 500 TABLET in 1 BOTTLE (0228-2029-50)Marketed from Oct 1, 1993 | |
| 0228-2029-96 | 00228202996 | 1000 TABLET in 1 BOTTLE (0228-2029-96)Marketed from Oct 1, 1993 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Alprazolam
- Generic name (nonproprietary)
- alprazolam
- Active ingredients
- Alprazolam — .5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Actavis Pharma, Inc.NDC labeler code 0228
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 074342
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Other FDA classes
- Benzodiazepines (Chemical structure)
- Identifiers
- Product ID 0228-2029_08d09d46-386d-4dc8-a0c1-5711261c6282SPL ID 08d09d46-386d-4dc8-a0c1-5711261c6282SPL set ID a23063c0-099a-4256-b95f-3a857bbf704bRxCUI 197321, 197322, 308047, 308048UNII YU55MQ3IZY
- Pharmacologic class
- Benzodiazepine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400228202910followed by a unit qualifier and the quantityPackage 00228-2029-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Alprazolam tablets are indicated for the: acute treatment of generalized anxiety disorder (GAD) in adults. treatment of panic disorder (PD), with or without agoraphobia in adults. Alprazolam tablets are a benzodiazepine indicated for the: Acute treatment of generalized anxiety disorder in adults. ( 1 ) Treatment of panic disorder with or without agoraphobia in adults. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0228-2029
- What is NDC 0228-2029?
- 0228-2029 is the product NDC for Alprazolam, Alprazolam .5 mg/1 tablet, listed with the FDA by Actavis Pharma, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Alprazolam.
- What is the active ingredient?
- Alprazolam.
- Who is the labeler?
- Actavis Pharma, Inc., NDC labeler code 0228. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Alprazolam?
- 114 other product NDCs are listed under this name. See all Alprazolam NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Alprazolam products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Alprazolam | Alprazolam 1 mg/1 | TabletOral | Coupler LLC | 67046-0007 | 67046-0007-03 |
| Alprazolam | Alprazolam .5 mg/1 | TabletOral | Coupler LLC | 67046-0154 | 67046-0154-03 |
| Alprazolam | Alprazolam .25 mg/1 | TabletOral | AvPAK | 50268-033 | 50268-0033-15 |
| Alprazolam | Alprazolam .5 mg/1 | TabletOral | AvPAK | 50268-034 | 50268-0034-15 |
| Alprazolam | Alprazolam 1 mg/1 | TabletOral | AvPAK | 50268-035 | 50268-0035-15 |
| Alprazolam | Alprazolam 1 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0444 | 80425-0444-0180425-0444-02 |
| Alprazolam | Alprazolam .25 mg/1 | TabletOral | Northwind Health Company, LLC | 82868-061 | 82868-0061-30 |
| Alprazolam | Alprazolam 1 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4137 | 70518-4137-00 |
| Alprazolam | Alprazolam .5 mg/1 | TabletOral | American Health Packaging | 60687-388 | 60687-0388-01 |
| Alprazolam | Alprazolam .25 mg/1 | TabletOral | American Health Packaging | 60687-377 | 60687-0377-01 |
Other NDCs under ANDA 074342
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Alprazolam | Alprazolam 1 mg/1 | TabletOral | Actavis Pharma, Inc. | 0228-2031 |
| Alprazolam | Alprazolam .5 mg/1 | TabletOral | A-S Medication Solutions | 50090-5078 |
| Alprazolam | Alprazolam .5 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-2220 |
| Alprazolam | Alprazolam .25 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-2292 |
| Alprazolam | Alprazolam .5 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-0849 |
| Alprazolam | Alprazolam .25 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-2133 |
| Alprazolam | Alprazolam .25 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-112 |
| Alprazolam | Alprazolam 1 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-113 |
| Alprazolam | Alprazolam .5 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-313 |
| Alprazolam | Alprazolam 1 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-328 |
| Alprazolam | Alprazolam .5 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0099 |
| Alprazolam | Alprazolam 1 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0110 |